Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) active agents. Its structure supports the creation of compounds with dopaminergic and serotonergic activity, making it valuable in researching treatments for neurological disorders such as Parkinson’s disease and depression. The presence of the trifluoromethoxy group enhances metabolic stability and membrane permeability, which improves bioavailability in drug candidates. It is also employed in the preparation of selective enzyme inhibitors and receptor modulators in medicinal chemistry research.